Bio Technology Techtransfer
Trauma remains a significant public health issue becoming the leading cause of death. Human serum albumin is the prime therapeutic protein administered in the patients suffering from it. Currently, HSA is primarily obtained from the fractionation of collected human blood, which is a limited and unsafe source possessing the risk of contamination by blood derived pathogens. Thus there exists an indispensable need to promote non animal derived rHSA production. Considering the availability of various FDA approved recombinant therapeutics produced in E. coli system, rHSA production using the same host can be of significant benefit for the desired applications. ....Ask for details